The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
Toshihiko DoiYutaka FujiwaraKohei ShitaraToshio ShimizuKan YonemoriNobuaki MatsubaraIzumi OhnoTakahiro KogawaYoichi NaitoLance LeopoldMihaela MunteanuNaoyoshi YatsuzukaShi Rong HanAyman SamkariNoboru YamamotoPublished in: Investigational new drugs (2020)
Epacadostat in combination with pembrolizumab was generally safe and well tolerated among Japanese patients with advanced solid tumors. Clinical trial registration NCT02862457.